Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multi-component prescription injection kit marketed as **Physician EZ Use Joint Tunnel and Trigger Kit** that combines **triamcinolone acetonide**, **lidocaine hydrochloride**, **povidone-iodine**, and **ammonia** for office-based musculoskeletal injection procedures. The therapeutic effect is primarily driven by triamcinolone acetonide, a synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to suppress inflammatory gene expression and reduce local inflammation in intra-articular and soft-tissue conditions; lidocaine hydrochloride provides local anesthesia by blocking voltage-gated sodium channels and inhibiting nerve impulse conduction, while povidone-iodine serves as a topical antiseptic and ammonia is included as an inhalant component. The kit was marketed by Asclemed USA for intramuscular and intra-articular use contexts, but the product is described as an unapproved drug product whose labeling has not been approved by the FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ammonia + povidone-iodine + lidocaine hydrochloride + triamcinolone.